EZH2 and breast carcinoma: In addition, cell cycle protein-dependent kinase 1 (CDK1)-mediated phosphorylation of threonines 345 and 487 promotes ubiquitinated degradation of EZH2 in breast cancer cells, cervical cancer cells, and LC cells (35).